Table 1 Comparison of general and clinical data between the two patient groups
| Â | Non-IMH group | IMH group | Statistical value | P value |
|---|---|---|---|---|
N = 107 | N = 109 |  |  | |
Age | 54.9 ± 12.1 | 54.5 ± 11.8 | t = 0.258 | 0.796 |
Gender | X2 = 0.201 | 0.654 | ||
 Male | 91 (85.0%) | 95 (87.2%) |  |  |
 Female | 16 (15.0%) | 14 (12.8%) |  |  |
BMI (kg/m2, x ± s) | 25.5 ± 3.04 | 26.0 ± 3.22 | t=-1.109 | 0.268 |
Heart rate | 77.9 ± 11.9 | 81.7 ± 12.3 | t=-2.320 | 0.021 |
Systolic blood pressure (mmHg) | 125 [112;140] | 120 [111;133] | Z= -1.342 | 0.180 |
Diastolic blood pressure (mmHg, x ± s) | 79.4 ± 14.0 | 81.1 ± 13.4 | t=-0.915 | 0.361 |
Medical history | ||||
Hypertension (Classification) | X2 = 4.471 | 0.215 | ||
 0 | 60 (56.1%) | 57 (52.3%) |  |  |
 1 | 9 (8.41%) | 4 (3.67%) |  |  |
 2 | 13 (12.1%) | 11 (10.1%) |  |  |
 3 | 25 (23.4%) | 37 (33.9%) |  |  |
Smoking history | X2 = 0.690 | 0.406 | ||
 No | 46 (43.0%) | 53 (48.6%) |  |  |
 Yes | 61 (57.0%) | 56 (51.4%) |  |  |
Dyslipidemia | X2 = 0.155 | 0.693 | ||
 No | 59 (55.1%) | 63 (57.8%) |  |  |
 Yes | 48 (44.9%) | 46 (42.2%) |  |  |
Diabetes | X2 = 1.093 | 0.296 | ||
 No | 85 (79.4%) | 80 (73.4%) |  |  |
 Yes | 22 (20.6%) | 29 (26.6%) |  |  |
History of drug use | ||||
Clopidogrel | X2 = 0.004 | 0.947 | ||
 No | 86 (80.4%) | 88 (80.7%) |  |  |
 Yes | 21 (19.6%) | 21 (19.3%) |  |  |
Beta-blocker | X2 = 0.690 | 0.406 | ||
 No | 61 (57.0%) | 56 (51.4%) |  |  |
 Yes | 46 (43.0%) | 53 (48.6%) |  |  |
ACEI/ARB | X2 = 0.323 | 0.569 | ||
 No | 63 (58.9%) | 60 (55.0%) |  |  |
 Yes | 44 (41.1%) | 49 (45.0%) |  |  |
Clinical data | ||||
Killip classification | X2 < 0.001 | 1.000 | ||
 I | 99 (92.5%) | 101 (92.7%) |  |  |
 II/III/IV | 8 (7.48%) | 8 (7.34%) |  |  |
ECG | X2 = 5.925 | 0.015 | ||
 STEMI | 78 (72.9%) | 94 (86.2%) |  |  |
 NSTEMI | 29 (27.1%) | 15 (13.8%) |  |  |
Criminal vessel | X2 = 16.153 | < 0.001 | ||
 LAD | 42 (39.3%) | 71 (65.1%) |  |  |
 LCX | 19 (17.8%) | 16 (14.7%) |  |  |
 RCA | 46 (43.0%) | 22 (20.2%) |  |  |
Time from symptom onset to reperfusion (min) | 360 [180;720] | 240 [180;420] | Z= -2.35 | 0.019 |
GLU (mmol/L) * | 5.69 [5.01;6.99] | 6.06 [5.05;8.32] | Z= -1.422 | 0.155 |
HbA1c (%) | 5.90 [5.60;6.65] | 5.90 [5.60;6.90] | Z= -0.387 | 0.699 |
CRP (mg/L) | 19.5 [8.10;42.3] | 39.1 [18.10;68.4] | Z= -3.945 | < 0.001 |
PLT / LYM | 89.1 [72.3;106] | 87.0 [72.7;109] | Z= -0.016 | 0.987 |
AST (U/L) | 119 [62.5;176] | 311 [215;508] | Z= -8.294 | < 0.001 |
ALT (U/L) | 39.0 [29.0;52.5] | 56.0 [39.0;75.0] | Z= -5.335 | < 0.001 |
LDH (×102U/L) | 5.89 [3.42;8.31] | 11.7 [7.64;19.50] | Z= -7.538 | < 0.001 |
CK (×103U/L) | 1.00 [0.52;1.54] | 3.84 [1.60;6.66] | Z= -8.247 | < 0.001 |
CKMB (ng/ml) | 72.2 [26.4;136] | 254 [130;300] | Z= -7.336 | < 0.001 |
HS-TnT (×103ng/L) | 1.90 [1.11;3.22] | 6.72 [4.10;9.75] | Z= -9.372 | < 0.001 |
NT-proBNP (×103pg/L) | 0.87 [0.47;1.44] | 1.33 [0.70;2.10] | Z= -3.048 | 0.002 |
SS (×10) | 1.80 [1.30;2.12] | 2.65 [2.25;3.25] | Z= -7.568 | < 0.001 |